- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PP0853 | Recombinant Protein-Salmonella enteritidis PT4 Major lipoprotein (a.a.25 to 80) | B5QVS6 | 100 µg | 1195 | |
PP0854 | Recombinant Protein-Salmonella enteritidis PT4 porin protein OmpD (a.a.32 to 362) | B5QTN0 | 100 µg | 1195 | |
PP0855 | Recombinant Protein-Salmonella enteritidis PT4 A (a.a.20 to 350) | B5QZG0 | 100 µg | 1195 | |
PP0856 | Recombinant Protein-Salmonella enteritidis PT4 F (a.a.29 to 363) | B5QZD3 | 100 µg | 1195 | |
PP0857 | Recombinant Protein-Salmonella enteritidis PT4 x (a.a.25 to 171) | B5QXT8 | 100 µg | 1195 | |
RPP0853 | cDNA-Salmonella enteritidis PT4 Major lipoprotein (a.a.25 to 80) | B5QVS6 | 2 µg | 800 | |
RPP0854 | cDNA-Salmonella enteritidis PT4 porin protein OmpD (a.a.32 to 362) | B5QTN0 | 2 µg | 1650 | |
RPP0855 | cDNA-Salmonella enteritidis PT4 A (a.a.20 to 350) | B5QZG0 | 2 µg | 1650 | |
RPP0856 | cDNA-Salmonella enteritidis PT4 F (a.a.29 to 363) | B5QZD3 | 2 µg | 1670 | |
RPP0857 | cDNA-Salmonella enteritidis PT4 x (a.a.25 to 171) | B5QXT8 | 2 µg | 730 |
Salmonella enteritidis cDNA and recombinant antigen
Salmonella Enteritidis PT4 is a strain of the bacterium Salmonella enterica that can cause gastroenteritis in humans. It is important to understand the proteins produced by this bacterium and their roles in the pathogenesis of the infection. In this article, we will explore the major lipoprotein and porin proteins produced by Salmonella Enteritidis PT4 and their functions.
Lipoprotein and porin proteins are important components of the outer membrane of gram-negative bacteria. These proteins play crucial roles in nutrient uptake, membrane stability, and interaction with host cells during infection.
One of the major lipoproteins produced by Salmonella Enteritidis PT4 is LppA. This protein is involved in the regulation of bacterial cell division and is necessary for the bacterium to colonize the intestinal tract of its host. LppA is also thought to play a role in the activation of the host’s immune system.
Another important protein produced by Salmonella Enteritidis PT4 is OmpD. This protein is a porin, which means it forms channels in the outer membrane of the bacterium that allow for the passage of small molecules like nutrients. OmpD is thought to play a role in the colonization of the intestinal tract, as well as in the resistance of the bacterium to the host’s immune system.
OmpA is another porin protein produced by Salmonella Enteritidis PT4. This protein is involved in the adhesion of the bacterium to host cells, and it is also thought to play a role in the activation of the host’s immune system. OmpA has been shown to be an important virulence factor in other strains of Salmonella enterica, and it is likely to play a similar role in Salmonella Enteritidis PT4.
OmpF is a porin protein that is also produced by Salmonella Enteritidis PT4. This protein is involved in the uptake of nutrients by the bacterium, and it is also thought to play a role in the resistance of the bacterium to the host’s immune system.
Finally, Salmonella Enteritidis PT4 produces the porin protein OmpX. This protein is involved in the resistance of the bacterium to the host’s immune system, and it is also thought to play a role in the adhesion of the bacterium to host cells.
In conclusion, lipoprotein and porin proteins play important roles in the pathogenesis of Salmonella Enteritidis PT4. These proteins are involved in nutrient uptake, membrane stability, colonization of the intestinal tract, adhesion to host cells, and resistance to the host’s immune system. Understanding the functions of these proteins is important for the development of new therapies to combat infections caused by this bacterium.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
The application of cDNA and recombinant Salmonella enteritidis antigens in the diagnosis of Salmonella enteritidis infection has been investigated in recent years. cDNA is a type of genetic material derived from a bacterial cell’s messenger RNA. It contains the genetic information necessary for the bacteria to produce proteins and other cellular components. Recombinant antigens are created by cloning the genes responsible to produce a particular antigen into a host cell. By using these two techniques, it is possible to create a highly specific test for Salmonella enteritidis infection.The use of cDNA and recombinant antigens in the diagnosis of Salmonella enteritidis infection has been found to be highly sensitive and specific. This method is also faster than traditional methods.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple